4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow gemcabene: new trials by email Literature Review of gemcabene trials Research Report on gemcabene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Gemcabene in Adults With FPLD 300mg Gemcabene, 600mg Gemcabene - Familial Partial Lipodystrophy, Hypertriglyceridemia | Phase 1 / Phase 2 | Completed | Elif Oral | 5 | 2018-03-13 | 2020-08-17 |
| Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers Gemcabene 300 mg, Gemcabene 900 mg, Atorvastatin - Hypercholesteremia | Phase 1 | Completed | NeuroBo Pharmaceuticals Inc. | 20 | 2002-11-01 | 2020-04-09 |
| Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers Gemcabene 900 mg, Simvastatin 80 mg - Hypercholesterolemia | Phase 1 | Completed | NeuroBo Pharmaceuticals Inc. | 20 | 2000-05-01 | 2020-04-09 |
| Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers Gemcabene 50 mg, Gemcabene 150 mg, Gemcabene 450 mg - Hypercholesterolemia | Phase 1 | Completed | NeuroBo Pharmaceuticals Inc. | 50 | 1999-04-01 | 2020-04-09 |
Hypercholesterolemia (3) · Fatty Liver (1) · Hypertriglyceridemia (1) · Lipodystrophy, Familial Partial (1) · Non-alcoholic Fatty Liver Disease (1)
NeuroBo Pharmaceuticals Inc. (3) · Elif Oral (1)
United States (1)